ADC Therapeutics S.A. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 20.9M | 23.1M | 16.4M | 18.8M | 23.0M | 16.9M | 18.5M | 17.4M |
| Cost of Goods Sold | 3.6M | 1.7M | 1.2M | 836K | 2.1M | 1.4M | 851K | 1.2M |
| Gross Profit | 17.2M | 21.4M | 15.2M | 18.0M | 21.0M | 15.5M | 17.6M | 16.2M |
| R&D Expenses | 19.9M | 18.2M | 26.8M | 30.1M | 28.9M | 27.1M | 32.5M | 24.3M |
| Operating Expenses | 42.5M | 39.5M | 45.6M | 62.1M | 49.4M | 48.0M | 53.2M | 45.2M |
| Operating Income | -25.2M | -18.1M | -30.3M | -44.1M | -28.5M | -32.4M | -35.6M | -29.0M |
| Other Income / Gains | -7.7M | 11.3M | -10.6M | -11.2M | -10.0M | 1.4M | -8.3M | -7.3M |
| Net Income | -33.0M | -6.4M | -41.0M | -56.6M | -38.6M | -30.7M | -44.0M | -36.5M |
| EPS (Diluted) | -0.21 | -0.043 | -0.30 | -0.50 | -0.36 | -0.29 | -0.42 | -0.38 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.827 | 0.926 | 0.927 | 0.956 | 0.911 | 0.919 | 0.954 | 0.93 |
| General And Administrative Expenses | 9.9M | 15.6M | 14.0M | 15.0M | 10.0M | 15.2M | 15.6M | 16.1M |
| Selling And Marketing Expenses | 12.7M | 5.9M | 5.0M | 4.0M | -10.6M | 5.7M | 5.1M | 4.8M |
| Selling General And Administrative Expenses | 22.6M | 21.4M | 19.0M | 19.0M | -598K | 20.9M | 20.7M | 20.9M |
| Other Expenses | 0 | -144K | -266K | 13.1M | 21.1M | 0 | 0 | 0 |
| Cost And Expenses | 46.1M | 41.2M | 46.8M | 63.0M | 51.5M | 49.3M | 54.0M | 46.5M |
| Interest Income | 2.0M | 2.4M | 2.5M | 1.9M | 2.1M | 2.6M | 3.4M | 3.3M |
| Interest Expense | 12.3M | 13.0M | 13.4M | 13.0M | 12.2M | 11.9M | 13.1M | 12.7M |
| Depreciation And Amortization | 113K | 113K | 122K | 840K | 801K | 793K | 802K | 838K |
| Ebitda | -20.5M | 6.3M | -27.5M | -41.6M | -25.7M | -18.8M | -29.7M | -22.2M |
| Ebitdaratio | -0.983 | 0.274 | -1.671 | -2.206 | -1.115 | -1.114 | -1.609 | -1.275 |
| Operating Income Ratio | -1.211 | -0.786 | -1.846 | -2.343 | -1.236 | -1.918 | -1.926 | -1.668 |
| Income Before Tax | -33.0M | -6.8M | -41.0M | -55.4M | -38.4M | -31.0M | -43.9M | -36.3M |
| Income Before Tax Ratio | -1.581 | -0.295 | -2.494 | -2.94 | -1.669 | -1.836 | -2.376 | -2.086 |
| Income Tax Expense | 0 | -404K | 0 | 1.3M | 165K | -321K | 90K | 234K |
| Net Income Ratio | -1.581 | -0.278 | -2.494 | -3.007 | -1.676 | -1.817 | -2.381 | -2.099 |
| Epsdiluted | -0.21 | -0.043 | -0.30 | -0.50 | -0.36 | -0.29 | -0.42 | -0.38 |
| Weighted Average Shs Out | 154.1M | 150.3M | 136.4M | 113.7M | 107.2M | 105.4M | 104.8M | 95.7M |
| Weighted Average Shs Out Dil | 154.1M | 150.3M | 136.4M | 113.7M | 107.2M | 105.4M | 104.8M | 95.7M |